TAUNS Laboratories, Inc.
JPX: 197A.T0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Tokyo Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Specialties
- CEO
- Masaki Nonaka
- Employees
- 271
- Headquarters
- Izunokuni, Japan
- IPO year
- 2024
- Market cap
- ¥54B
- Website
- http://www.tauns.co.jp
Loading 197A…
Loading profile data…Frequently asked questions about 197A
What does TAUNS Laboratories, Inc. (197A.T) do?
TAUNS Laboratories, Inc. develops and manufactures vitro diagnostic drugs & measuring instruments. It also provides import and export of industrial measuring instruments, medical, physical, chemical and measuring instruments. The company was founded in April 1987 and is headquartered in Izunokuni, Japan.
Where does 197A.T trade?
TAUNS Laboratories, Inc. (197A.T) trades on the Tokyo Stock Exchange.
What sector is 197A.T in?
TAUNS Laboratories, Inc. (197A.T) operates in the Healthcare sector, specifically in the Medical - Specialties industry.
Who is the CEO of TAUNS Laboratories, Inc.?
Masaki Nonaka is the chief executive officer of TAUNS Laboratories, Inc. (197A.T).
Where is TAUNS Laboratories, Inc. headquartered?
TAUNS Laboratories, Inc. is headquartered in Japan.
Does 197A.T pay a dividend?
Yes — TAUNS Laboratories, Inc. (197A.T) paid a trailing twelve-month dividend of JPY 28.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 197A.T go public?
TAUNS Laboratories, Inc. (197A.T) completed its initial public offering in 2024.